Structure-Based Design for High-Hanging Vaccine Fruits

被引:6
|
作者
Back, Jaap W. [2 ]
Langedijk, Johannes P. M. [1 ]
机构
[1] Crucell Innovat & Discovery Lab, Leiden, Netherlands
[2] Pepscan Therapeut, Lelystad, Netherlands
来源
ADVANCES IN IMMUNOLOGY , VOL 114: SYNTHETIC VACCINES | 2012年 / 114卷
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; HIV-1; GP120; BROAD NEUTRALIZATION; CRYSTAL-STRUCTURES; MOUTH-DISEASE; BINDING MODE; GP41; EPITOPE;
D O I
10.1016/B978-0-12-396548-6.00002-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although vaccines have proven life saving against a myriad of infectious diseases, various pathogens have remained refractory to prophylaxis of their host by active immunization. New insights in the three dimensional (3D) structure, domain organization and dynamics of viral and bacterial surface proteins can guide the design of effective vaccines in several ways. In this review we highlight recent developments in structure-based vaccine design that are aimed at stabilization of native conformations and focusing immune response to conserved epitopes. Detailed 3D structures of pathogen surface proteins provide knowledge on how to minimize complex antigens or how to redesign the surface of an immunogen in order to induce only relevant neutralizing antibodies against a broad range of serotypes. Structure - based vaccines with reduced complexity and broad efficacy could greatly enhance the number of people that might benefit from the therapies that are developed.
引用
收藏
页码:33 / 50
页数:18
相关论文
共 50 条
  • [41] STRUCTURE-BASED DRUG DESIGN
    COLMAN, PM
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1994, 4 (06) : 868 - 874
  • [42] Structure-based drug design
    Blundell, TL
    NATURE, 1996, 384 (6604) : 23 - 26
  • [43] Structure-based drug design
    Amzel, LM
    CURRENT OPINION IN BIOTECHNOLOGY, 1998, 9 (04) : 366 - 369
  • [44] High-throughput structure-based drug design.
    Jorgensen, WL
    Tirado-Rives, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U899 - U899
  • [45] De novo structure-based design of high symmetry assemblies
    Hay, Benjamin P.
    Custelcean, Radu
    Duncan, Nathan C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [46] Structure-based Vaccine Development (Structural Vaccinology)
    Malito, E.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C697 - C697
  • [47] Mechanistic insights into the structure-based design of a CspZ-targeting Lyme disease vaccine
    Brangulis, Kalvis
    Malfetano, Jill
    Marcinkiewicz, Ashley L.
    Wang, Alan
    Chen, Yi-Lin
    Lee, Jungsoon
    Liu, Zhuyun
    Yang, Xiuli
    Strych, Ulrich
    Tupina, Dagnija
    Akopjana, Inara
    Bottazzi, Maria-Elena
    Pal, Utpal
    Hsieh, Ching-Lin
    Chen, Wen-Hsiang
    Lin, Yi-Pin
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [48] Structure-based Vaccine Design of Human Rhinovirus: HIV Chimeras as Candidate AIDS Vaccines
    Arnold, Eddy
    Frenkel, Yulia V.
    Oren, Deena A.
    Hughes, Scott A.
    Elsasser, Denise A.
    Clark, Arthur D., Jr.
    Velasco, Paola A.
    Ding, Jianping
    Arnold, Gail Ferstandig
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C51 - C51
  • [49] Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder
    Le Grice, Stuart F. J.
    FUTURE OF HIV-1 THERAPEUTICS: RESISTANCE IS FUTILE?, 2015, 389 : 147 - 169
  • [50] Beyond Budgeting - a high-hanging fruit The impact of managers' mindset on the advantages of Beyond Budgeting
    Heupel, Thomas
    Schmitz, Sven
    4TH WORLD CONFERENCE ON BUSINESS, ECONOMICS AND MANAGEMENT (WCBEM-2015), 2015, 26 : 729 - 736